Adicet Bio Inc (NASDAQ: ACET) kicked off on Monday, down -5.25%% from the previous trading day, before settling in for the closing price of $0.67. Over the past 52 weeks, ACET has traded in a range of $0.45-$1.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 36.74%. While this was happening, its average annual earnings per share was recorded 24.19%. With a float of $65.35 million, this company’s outstanding shares have now reached $82.71 million.
Considering the fact that the conglomerate employs 152 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Adicet Bio Inc (ACET) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adicet Bio Inc is 20.99%, while institutional ownership is 49.04%.
Adicet Bio Inc (ACET) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.34% during the next five years compared to 36.74% growth over the previous five years of trading.
Adicet Bio Inc (NASDAQ: ACET) Trading Performance Indicators
Take a look at Adicet Bio Inc’s (ACET) current performance indicators. Last quarter, stock had a quick ratio of 9.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.29, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.89 in one year’s time.
Technical Analysis of Adicet Bio Inc (ACET)
Compared to the last year’s volume of 0.68 million, its volume of 0.36 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 3.30%.
During the past 100 days, Adicet Bio Inc’s (ACET) raw stochastic average was set at 28.45%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.81% in the past 14 days, which was lower than the 108.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6626, while its 200-day Moving Average is $0.9724. Nevertheless, the first resistance level for the watch stands at $0.6633 in the near term. At $0.6967, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7133. If the price goes on to break the first support level at $0.6133, it is likely to go to the next support level at $0.5967. Should the price break the second support level, the third support level stands at $0.5633.
Adicet Bio Inc (NASDAQ: ACET) Key Stats
The company with the Market Capitalisation of 52.51 million has total of 82,710K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -117,120 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -28,210 K.
